Nurexone Biologic Inc
F:J90
Nurexone Biologic Inc
Other Items
Nurexone Biologic Inc
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nurexone Biologic Inc
F:J90
|
Other Items
-$9k
|
CAGR 3-Years
83%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Enerflex Ltd
TSX:EFX
|
Other Items
CA$12m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-5%
|
|
|
T
|
TerraVest Industries Inc
TSX:TVK
|
Other Items
-CA$880.2m
|
CAGR 3-Years
-201%
|
CAGR 5-Years
-202%
|
CAGR 10-Years
-49%
|
|
|
CES Energy Solutions Corp
TSX:CEU
|
Other Items
-CA$3.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
|
Secure Energy Services Inc
TSX:SES
|
Other Items
-CA$140m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-13%
|
|
|
H
|
HydroGraph Clean Power Inc
CNSX:HG
|
Other Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nurexone Biologic Inc
Glance View
NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles (EV)-based technology drug platform. The company is headquartered in Edmonton, Alberta. The company went IPO on 2012-05-08. The firm is developing a biological extracellular vesicles (EV)-based technology drug platform. The technology drug platform offers treatment for reversing paralysis and improving the life of patients following spinal cord injury using bio-guided exosomes (membrane-bound extracellular vesicles) loaded with modified small interfering RNA (siRNA) sequence. Its technology is used to treat various conditions, such as spinal cord injury, traumatic brain injury, and other brain and neurological indications. The firm also has developed exosome manufacturing process. The company is also focused on exosome research, management of clinical studies and commercialization of the technology for different indications, not limited to the central nervous system.
See Also
What is Nurexone Biologic Inc's Other Items?
Other Items
-9k
USD
Based on the financial report for Dec 31, 2024, Nurexone Biologic Inc's Other Items amounts to -9k USD.
What is Nurexone Biologic Inc's Other Items growth rate?
Other Items CAGR 3Y
83%
The average annual Other Items growth rates for Nurexone Biologic Inc have been 83% over the past three years .
